GLOBE & GUARD Model - Evaluation Contract
Past New Requirement Updated
- Agency
-
Centers for Medicare and Medicaid Services
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $10,000,000 to $20,000,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541720 Research and Development in the Social Sciences and Humanities
- Forecast number
- 270037
- Points of contact
Forecast details come from CMS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Centers for Medicare and Medicaid Services is procuring research and development services to evaluate the GLOBE (Global Benchmark for Efficient Drug Pricing) and GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Models, with solicitation release estimated for September 1, 2026 and award anticipated in December 2026. The GLOBE Model is a proposed mandatory model assessing rebates for certain Medicare Part B drugs if prices exceed those paid in economically comparable countries, while the GUARD Model assesses rebates for certain Medicare Part D drugs under the same pricing comparison framework. This competitive order will be placed against the CMS Research, Measurement, Assessment, Design and Analysis (RMADA) 2 IDIQ.
The estimated award value ranges from $10 million to $20 million under a Cost Plus Fixed Fee pricing structure with a contract period exceeding five years beginning December 1, 2026. Work will be performed within the Centers for Medicare & Medicaid Services' Center for Medicare & Medicaid Innovation (CMMI), reporting to the Research, Rapid Cycle Evaluation Group (RRCEG). Inquiries should be directed to Contracting Officer John Cruse at john.cruse1@cms.hhs.gov or 410-786-7762, with Caroline Ly at caroline.ly@cms.hhs.gov or 410-786-8114 listed as an additional point of contact.
Forecast text
GLOBE (Global Benchmark for Efficient Drug Pricing) Model. The Global Benchmark for Efficient Drug Pricing (GLOBE) Model is a proposed mandatory model that would assess a rebate for certain drugs payable under Medicare Part B if the prices exceed those paid in economically comparable countries. GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Model is a proposed mandatory model that would assess rebates for certain drugs payable under Medicare Part D if the prices exceed those paid in economically comparable countries.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast